Carcinoid Tumors
January 2017 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Sincerely,
Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Diagnosis and Management of Hereditary Carcinoids.
Authors:Benafif S, Eeles R
Institution:The Institute of Cancer Research, Sutton, Surrey, UK.
Journal:Recent Results Cancer Res. 2016;205:149-68. doi: 10.1007/978-3-319-29998-3_9.

2:Laparoscopic antrectomy: a safe and definitive treatment in managing type 1 gastric carcinoids.
Authors:Jenny HE, Ogando PA, Fujitani K, Warner RR, Divino CM
Institution:Division of General Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1259, New York, NY, 10029, USA. Mount Sinai, One Gustave L. Levy Place Box 1259, New York, NY, 10029, USA. Mount Sinai, One Gustave L. Levy Place Box 1259, New York, NY, 10029, USA. Mount Sinai, New York, NY, USA; Center for Carcinoid and Neuroendocrine Tumors, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Mount Sinai, One Gustave L. Levy Place Box 1259, New York, NY, 10029, USA; Center for Carcinoid and Neuroendocrine Tumors, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: celia.divino@mountsinai.org.
Journal:Am J Surg. 2016 Apr;211(4):778-82. doi: 10.1016/j.amjsurg.2015.08.040. Epub 2016 Jan 15.

3:Outcomes after surgical resection of pulmonary carcinoid tumors.
Authors:Okereke IC, Taber AM, Griffith RC, Ng TT
Institution:Cardiothoracic Surgery, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. iokereke@usasurg.org. Providence, RI, USA. Brown University, Providence, RI, USA. Providence, RI, USA.
Journal:J Cardiothorac Surg. 2016 Mar 2;11:35. doi: 10.1186/s13019-016-0424-0.

4:Diagnosis and management of typical and atypical lung carcinoids.
Authors:Pusceddu S, Lo Russo G, Macerelli M, Proto C, Vitali M, Signorelli D, Ganzinelli M, Scanagatta P, Duranti L, Trama A, Buzzoni R, Pelosi G, Pastorino U, de Braud F, Garassino MC
Institution:Medical Oncology Department, Fondazione IRCCS Istituto Nazionale di Tumori, Via G. Venezian 1, 20133 Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.; Division of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milan, Italy.; Department of Preventive and Predictive Medicine, Fondazione IRCSS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milan, Italy.; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milan, Italy.
Journal:Crit Rev Oncol Hematol. 2016 Apr;100:167-76. doi: 10.1016/j.critrevonc.2016.02.009. Epub 2016 Feb 18.

5:Cutaneous and Subcutaneous Metastases From Atypical Laryngeal Carcinoids: Case Report and Review of the Literature.
Authors:Wang KR, Jia YJ, Zhou SH, Wang QY, Bao YY, Feng ZY, Yao HT, Fan J
Institution:From the Department of Anaesthesia (K-RW, Z-YF); Department of Otolaryngology (Y-JJ, S-HZ, Q-YW, Y-YB); Department of Pathology (H-TY); and State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, China (JF).
Journal:Medicine (Baltimore). 2016 Feb;95(7):e2796. doi: 10.1097/MD.0000000000002796.

6:Significance of the resection margin in bronchopulmonary carcinoids.
Authors:Schmid S, Aicher M, Csanadi A, Passlick B, Kaifi JT
Institution:Department of Thoracic Surgery, University Medical Center Freiburg, Freiburg, Germany. Electronic address: Severin.Schmid@uniklinik-freiburg.de. Germany. Germany. Germany.
Journal:J Surg Res. 2016 Mar;201(1):53-8. doi: 10.1016/j.jss.2015.09.036. Epub 2015 Oct 3.

7:Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease.
Authors:Jahagirdar V, Kamal A, Steeds R, Ayuk J
Institution:Department of Diabetes and Endocrinology, Birmingham Heartlands Hospital, Birmingham, UK. Birmingham, UK.
Journal:BMJ Case Rep. 2016 Feb 3;2016. pii: bcr2015213693. doi: 10.1136/bcr-2015-213693.

8:Two rare cases of appendiceal collision tumours involving an appendiceal mucinous neoplasm and carcinoid.
Authors:Tan HL, Tan GH, Teo M
Institution:Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore. Singapore. Singapore.
Journal:BMJ Case Rep. 2016 Feb 1;2016. pii: bcr2015213938. doi: 10.1136/bcr-2015-213938.

9:Cardiothoracic manifestations of neuroendocrine tumours.
Authors:Mandegaran R, David S, Screaton N
Institution:1 Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Greenwich NHS Trust, London, UK. Everard Hospital, Cambridge, UK.
Journal:Br J Radiol. 2016;89(1060):20150787. doi: 10.1259/bjr.20150787. Epub 2016 Jan 19.

10:Carcinoid Heart Disease without Severe Tricuspid Valve Involvement.
Authors:Killu AM, Newman DB, Miranda WR, Maleszewski JJ, Pellikka P, Schaff HV, Connolly HM
Institution:Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn., USA.
Journal:Cardiology. 2016;133(4):217-22. doi: 10.1159/000441488. Epub 2015 Dec 15.

11:Combined Bronchial Artery Embolization and Endobronchial Resection for Bronchial Carcinoid: A Safety and Feasibility Pilot Study.
Authors:Salamonsen M, Tazi-Mezalek R, Lopez-Lisbona R, Cubero N, Baixeras N, Dominguez J, Dorca J, Rosell A
Institution:Department of Respiratory Medicine, Bellvitge Hospital, Barcelona, Spain.
Journal:Respiration. 2016;91(1):63-8. doi: 10.1159/000442487. Epub 2015 Dec 3.

12:Bronchial and Thymic Carcinoid Tumors.
Authors:Litvak A, Pietanza MC
Institution:Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA. Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, 300 East 66th Street, New York, NY 10065, USA. Electronic address: pietanzm@mskcc.org.
Journal:Hematol Oncol Clin North Am. 2016 Feb;30(1):83-102. doi: 10.1016/j.hoc.2015.09.003.

13:When and how should patients with multiple endocrine neoplasia type 1 be screened for thymic and bronchial carcinoid tumours?
Authors:Singh Ospina N, Maraka S, Montori V, Thompson GB, Young WF Jr
Institution:Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Surgery, Mayo Clinic, Rochester, MN, USA.
Journal:Clin Endocrinol (Oxf). 2016 Jan;84(1):13-6. doi: 10.1111/cen.12972. Epub 2015 Dec 10.

14:Long-term results of PRRT in advanced bronchopulmonary carcinoid.
Authors:Mariniello A, Bodei L, Tinelli C, Baio SM, Gilardi L, Colandrea M, Papi S, Valmadre G, Fazio N, Galetta D, Paganelli G, Grana CM
Institution:Division of Nuclear Medicine, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy. annap_mar@hotmail.it. 20141, Milan, Italy. Italy. 20141, Milan, Italy. 20141, Milan, Italy. 20141, Milan, Italy. 20141, Milan, Italy. Institute of Oncology, Milan, Italy. Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. 20141, Milan, Italy.
Journal:Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):441-52. doi: 10.1007/s00259-015-3190-7. Epub 2015 Sep 21.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 20% Discount


Medifocus Guidebook on Carcinoid Tumors

Updated: January 30, 2017
144 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

CT12357822

Coupon Expires: April 25, 2017



What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
P.T.
Newcastle, England


"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
F.B.
Nanaimo, British Columbia


"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
J.P.F.
Agoura Hills, California



  
Medifocus Digest Alert is published monthly by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2013 Medifocus, Inc. All rights reserved.